What happens when a leader combines an M&A mindset with an operator’s commitment to people, process, and continuous transformation? In this episode of Transformational Thinkers with Sara Sheehan, host Sara Sheehan welcomes healthcare entrepreneur and operator Dalbir Bains to explore acquisitions, business transformation, AI in pharmaceutical manufacturing, and servant leadership. Dalbir shares how his early experience at Canwest Global shifted his focus from completing transactions to creating real operational value as a builder and operator.
When Dalbir cofounded Amenity Health and began acquiring independent pharmacies in underserved communities, his first acquisition taught him an important lesson about the pace of transformation. His team moved quickly to introduce new medical services without spending enough time understanding the previous owner, employees, community, and existing business. After going on to make 55 acquisitions, Dalbir says the most challenging part of integration remains people and culture. Trust requires consistency, communication, empathy, and time, while one-on-one conversations uncover concerns that may never surface in a group setting.
Sara and Dalbir also examine the lessons of an acquisition that ultimately had to be written off, his successful healthcare exits, and the differences between operating in public and private companies. Across these experiences, Dalbir emphasizes strategic discipline, stakeholder relationships, and building businesses that create genuine value. His experience demonstrates why successful M&A integration involves much more than financial strategy. Leaders must understand the people behind the business and earn their trust.
The conversation then turns to Galaxy Pharmaceuticals, 503B pharmaceutical manufacturing, and the potential for AI in regulated healthcare. Dalbir explains how AI can help manage complex information, strengthen process controls, identify potential issues, and support quality teams while keeping humans firmly in the loop. He also shares his approach to deciding whether to build AI technology or integrate an existing solution, and how leaders can turn employee resistance and concerns about AI into constructive feedback that improves technology and adoption.
Throughout the conversation, one principle connects Dalbir’s experiences in M&A, healthcare, pharmaceutical manufacturing, and AI: transformation depends on people. His enduring operating principle is servant leadership: serving people and the organization with humility and helping employees, clients, and investors succeed. For CEOs, entrepreneurs, executives, and transformational thinkers, this episode offers practical insights into M&A integration, AI adoption, organizational transformation, and building trust while leading through change.
Key Moments:
00:00 — From Corporate Executive to Builder and Operator
Dalbir shares how his experience at Canwest Global shifted his focus from transactions and finance to building businesses and creating operational value.
03:24 — The First Acquisition and an Early Lesson in Trust
Dalbir reflects on his first Amenity Health acquisition and why moving too quickly taught him to prioritize relationships, community knowledge, and trust.
06:12 — What 55 Acquisitions Teach You About People and Culture
After dozens of acquisitions, Dalbir explains why people, culture, communication, and trust remain the most challenging parts of integration.
09:13 — Using One-on-One Conversations to Uncover Concerns
Dalbir discusses why individual conversations during due diligence and onboarding can reveal needs and concerns that may never emerge in a group setting.
09:59 — A Failed Acquisition and the Cost of Misreading People
Dalbir examines an acquisition outside the company’s core business that ultimately failed and the lessons he learned about evaluating people and intentions.
11:32 — Building Healthcare Companies for Value and Successful Exits
Sara and Dalbir discuss the exits of Amenity Health and FGC Health and his focus on building strong businesses that solve meaningful healthcare problems.
13:19 — Public Versus Private Company Stakeholder Management
Dalbir compares the pressures of public company governance and investor relations with the greater flexibility available when building a private company.
16:28 — Entering 503B Pharmaceutical Manufacturing
Dalbir explains why he entered highly regulated pharmaceutical manufacturing and saw an opportunity to address drug shortages and underserved healthcare needs.
18:40 — Using AI to Transform Pharmaceutical Operations
Dalbir describes how AI can help manage the immense volume of data, procedures, and workflow requirements involved in regulated pharmaceutical manufacturing.
20:21 — Turning an Internal AI Strategy Into a Business Opportunity
Industry conversations helped Dalbir recognize that the regulatory and operational challenges his team was solving with AI were shared across the marketplace.
23:10 — Quality, FDA Requirements, and Keeping Humans in the Loop
Dalbir explains the quality function’s role in regulated manufacturing and why human accountability remains essential when incorporating AI.
24:54 — Build or Buy? Choosing the Right AI Solution
Dalbir shares his requirements-first approach to deciding whether to integrate existing AI technology or build a solution for a unique business problem.
27:37 — How AI Changes Quality and Work on the Shop Floor
Dalbir explains how AI can strengthen process controls, identify potential problems earlier, and improve quality while reducing the time required for certain tasks.
28:56 — Turning AI Resistance Into Constructive Feedback
Rather than dismissing concerns about hallucinations and incorrect outputs, Dalbir explains how leaders can use employee feedback to improve AI models and adoption.
30:02 — Servant Leadership as an Operating Principle
Dalbir identifies servant leadership, humility, and helping others succeed as the principles he has carried across the businesses he has built.
30:38 — Where to Follow Dalbir’s Work
Dalbir shares where listeners can learn more about his work with Galaxy Pharmaceuticals and his technology initiatives.
___
About Dalbir Bains:
Dalbir Bains is a founder, CEO, and transformational business leader with deep experience in regulated healthcare, artificial intelligence, M&A, and strategic growth. His career includes approximately 55 healthcare acquisitions, more than $120 million in growth capital raised, and two healthcare platform exits at 10x and 8x EBITDA. His broader M&A experience includes public company transactions, with his personal site reporting more than $3.2 billion in enterprise value across 100 media acquisitions.
Dalbir is the Founder and CEO of Tek HQS AI, a custom AI company focused on regulated healthcare, and is also building Galaxy Pharmaceuticals, a 503B sterile pharmaceutical operation in New York. His approach to AI emphasizes validated technology, human accountability, quality oversight, and solutions designed to withstand the requirements of highly regulated healthcare environments.
Throughout his career, Dalbir has used M&A, operational excellence, technology, and high-performance teams to drive growth, profitability, and strategic transformation. His leadership approach combines visionary thinking with disciplined execution to create long-term value for organizations, investors, employees, and the communities they serve.
Resources mentioned in this episode:
- Galaxy Pharmaceuticals: GalaxyPharma.net
- Tech HQS: TekHQS.ai
__
Contact Sara Sheehan | Sara Sheehan Consulting:
Contact Dalbir Bains:
- Website: DalbirBains.com
- LinkedIn: Dalbir-Bains
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
